CareersInvestor RelationsPress RoomCOVID-19
  1. Home
  2. Digital Health Solutions
  3. Digital portfolio overview
  4. Supporting diagnostic and therapeutic decision-making
  5. Feedback form
AI-Rad Companion - Feedback Form

Feedback formAI-Rad Companion Prostate MR

Dear User/Customer,

We very much appreciate that you are taking the time to support us, by filling out this anonymous survey.
Your answers will help us to design products that best fit your needs.
Overall it should not take you more than 5-10 minutes to fill out the questions.
The product family at the core of this questionnaire is the AI-Rad Companion, specifically we would like to focus on the Prostate MR extension.

In the following section you find all the insights you need to know to better understand the product and its clinical capabilities.

Please have a look, learn more about the AI-Rad Companion and fill out the questionnaire directly in the browser.

Thank you very much in advance for your support.

General introduction AI-Rad Companion

The AI-Rad Companion is a family of algorithms that is made available through the teamplay Digital Health Platform.

The purpose is to automatically post-process imaging scans, segment relevant anatomies and do different quantifications of interest to:

1. support clinical quality,
2. increase efficiency
3. increase the reader’s confidence.

Scans are directly sent from the scanner to the AI-Rad Companion, post-processed and sent back to the PACS. There the enriched data sets are available when the patient is opened for image interpretation.
The AI-Rad Companion can be used with scanners from a variety of vendors, not only with equipment from Siemens Healthineers.

AI-Rad Companion Prostate MR
AI-Rad Companion Prostate MR

    The AI-Rad Companion Prostate MR in the context of MR-US fusion biopsy

    A prostate biopsy is usually performed with an MR/US-fusion biopsy meaning that the MR images are overlaid on real-time US images during the procedure in order to target a lesion for biopsy. The urologist must identify where the potential
    tumor is located based on the radiologist’s report and the existing MR images.
    AI-Rad Companion Prostate MR (FDA 510(k) pending) helps to standardize and ease this workflow by automatically segmenting the prostate and performing volumetry of the prostate gland. The prostate gland is automatically detected and displayed as contour for the radiologist. The volume of the segmentation gland is automatically computed and provided for inclusion in the final report. The results can be exported as a RTSS object which is then used in TRUS-guided biopsy by the urologist.

    The follow clinical outcomes are generated by the AI-Rad Companion Prostate MR:

    Prostate MR
    AI-Rad Companion Prostate MR Vida Segmentation
    AI-Rad Companion Prostate MR for biopsy support performs an automated segmentation as well as an automated volume estimation of the prostate. In case the PSA value is known, it calculates the PSA density.

      Please answer the following questions:

      General:

      AI-Rad Companion Prostate MR is pending 510(k) clearance, and is not yet commercially available in the United States. This product does not fulfill all the essential requirements according to the European Medical Device Directive (93/42/EEC) and its national implementations. It is not commercially available in the European Union. Its future availability cannot be ensured.